HIV Opportunistic Infection Treatment Guidelines for Adults and Adolescents

Clinical guidelines for treating 28 opportunistic infections in HIV-infected adults and adolescents, developed by the CDC, NIH, and HIV Medicine Association/IDSA. The document provides evidence-based recommendations covering epidemiology, diagnosis, treatment, and special considerations for each infection. It includes tables on drug dosing, toxicities, interactions, and use in pregnancy.

Use Cases

• Extract structured treatment recommendations based on the detailed guidelines for 28 specific infections.
• Analyze drug dosing and interaction information based on the tables mentioned in the description.
• Identify special clinical considerations based on the sections covering pregnancy and management of treatment failure.

Strengths

• Covers 28 distinct opportunistic infections, providing broad clinical scope.
• Includes specific sections on epidemiology, clinical manifestations, diagnosis, and treatment for each condition.
• Provides tables addressing drug doses, toxicities, and interactions, suggesting structured supplementary data.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

CDC, National Institutes of Health, HIV Medicine Association/Infectious Diseases Society of America

Collection Method

Evidence-based guideline development.

Geography

Primarily United States, with consideration of infections endemic elsewhere.